0001104659-23-119212.txt : 20231116
0001104659-23-119212.hdr.sgml : 20231116
20231116200510
ACCESSION NUMBER: 0001104659-23-119212
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231114
FILED AS OF DATE: 20231116
DATE AS OF CHANGE: 20231116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Emany Sravan Kumar
CENTRAL INDEX KEY: 0001897662
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39294
FILM NUMBER: 231416139
MAIL ADDRESS:
STREET 1: 100 SUMMER ST
STREET 2: SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Assertio Holdings, Inc.
CENTRAL INDEX KEY: 0001808665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850598378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 S. SAUNDERS ROAD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: (224) 419-7106
MAIL ADDRESS:
STREET 1: 100 S. SAUNDERS ROAD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
4
1
tm2330756-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-11-14
0
0001808665
Assertio Holdings, Inc.
ASRT
0001897662
Emany Sravan Kumar
ASSERTIO HOLDINGS, INC.
100 SOUTH SAUNDERS ROAD, SUITE 300
LAKE FOREST
IL
60045
1
0
0
0
0
Common Stock
2023-11-14
4
A
0
177570
0
A
177570
D
Stock Option (right to buy)
1.07
2023-11-14
4
A
0
26308
0
A
2023-11-14
Common Stock
26308
26308
D
Restricted stock units were granted in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy on the effective date the Issuer appointed the Reporting Person to serve on its Board of Directors. One-third of these restricted stock units are scheduled to vest on each of November 14, 2024, 2025 and 2026, assuming continued service through the applicable vesting date.
Stock options were granted in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy on the effective date the Issuer appointed the Reporting Person to serve on its Board of Directors. One-third of these stock options are scheduled to vest on each of November 14, 2024, 2025 and 2026, assuming continued service through the applicable vesting date.
These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities.
/s/ Sam Schlessinger, Attorney-in-fact for Sravan K. Emany
2023-11-16